Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Clipan Finance Indonesia Tbk. (CFIN) vs Medela Potentia Tbk. (MDLA) Price & Performance

Clipan Finance Indonesia Tbk.Trade
Medela Potentia Tbk.Trade

Price performance (Past 24H)

Key statistics

Clipan Finance Indonesia Tbk. vs Medela Potentia Tbk. — how do they compare? Clipan Finance Indonesia Tbk. trades at Rp336 (market cap 1.33T, 3.2K 24h volume), while Medela Potentia Tbk. trades at Rp208 (market cap 2.89T, 23.4K 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 2.2× Clipan Finance Indonesia Tbk.'s market cap, and Medela Potentia Tbk. is more actively traded (23.4K versus 3.2K). Which is the better fit depends on your goals.

CFINMDLA
Market Cap
1.33T2.89T
Volume
3.2K23.4K
Lot
32234
Turnover
1.07M4.79M
Average Price
335.44204.62
Value
1.07M4.79M
Indicative Equilibrium Price
336206
Indicative Equilibrium Volume
16900

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CFIN
View details
MDLA
View details

About Clipan Finance Indonesia Tbk.

PT Clipan Finance Indonesia Tbk (the Company) was established on January 15, 1982 based on the notarial deed No.47 of Kartini Muljadi SH. The Deed of establishment was approval by the Ministry of Justice with his decision letter No. C2-396-HT.01Th.82 on August 2, 1982 and was published on State Gazette No.79 dated October 1, 1982, Supplement No.1189. The article of association have been change several times, most recently on June 29 1998 concerning among others, the change in the Authorized capital and par value of share. The Company is located in Jakarta and the branches is in Denpasar. The Company is affiliated by Panin Group.

Read more on CFIN

About Medela Potentia Tbk.

PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.

Read more on MDLA